Nemosis of fibroblasts is inhibited by benign HaCaT keratinocytes but promoted by malignant HaCaT cells

Molecular Oncology

Volumn 2, Issue 4, 2008, Pages 340-348

  Räsänen, Kati ^a   Salmenperä, Pertteli ^a   Baumann, Marc ^b   Virtanen, Ismo ^b   Vaheri, Antti ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Fibroblast; Growth factors; Keratinocyte; Nemosis

Indexed keywords

COLLAGEN; CYCLOOXYGENASE 2; NEUTRALIZING ANTIBODY; SCATTER FACTOR; VASCULOTROPIN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL AGGREGATION; CELL CULTURE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; KERATINOCYTE; MYOFIBROBLAST; NEMOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SPHEROID CELL;

CELL ADHESION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; COCULTURE TECHNIQUES; CYCLOOXYGENASE 2; FIBROBLASTS; HEPATOCYTE GROWTH FACTOR; HUMANS; KERATINOCYTES; SKIN NEOPLASMS; T-LYMPHOCYTES; TRANSCRIPTIONAL ACTIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 56349144709     PISSN: 15747891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molonc.2008.09.002     Document Type: Article

References (35)

1. Atula S., Grenman R., and Syrjanen S. Fibroblasts can modulate the phenotype of malignant epithelial cells in vitro. Exp. Cell Res. 235 (1997) 180-187
2. Bachmeier B.E., Boukamp P., Lichtinghagen R., Fusenig N.E., and Fink E. Matrix metalloproteinases-2,-3,-7,-9 and -10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines. Biol. Chem. 381 (2000) 497-507
3. Baglole C.J., Ray D.M., Bernstein S.H., Feldon S.E., Smith T.J., Sime P.J., and Phipps R.P. More than structural cells, fibroblasts create and orchestrate the tumor microenvironment. Immunol. Invest 35 (2006) 297-325
4. Bizik J., Kankuri E., Ristimäki A., Taieb A., Vapaatalo H., Lubitz W., and Vaheri A. Cell-cell contacts trigger programmed necrosis and induce cyclooxygenase-2 expression. Cell Death Differ 11 (2004) 183-195
5. Boccaccio C., Sabatino G., Medico E., Girolami F., Follenzi A., Reato G., Sottile A., Naldini L., and Comoglio P.M. The MET oncogene drives a genetic programme linking cancer to haemostasis. Nature 434 (2005) 396-400
6. Cunha G.R., Hayward S.W., Wang Y.Z., and Ricke W.A. Role of the stromal microenvironment in carcinogenesis of the prostate. Int. J. Cancer 107 (2003) 1-10
7. De Wever O., and Mareel M. Role of tissue stroma in cancer cell invasion. J. Pathol 200 (2003) 429-447
8. Delehedde M., Lyon M., Vidyasagar R., McDonnell T.J., and Fernig D.G. Hepatocyte growth factor/scatter factor binds to small heparin-derived oligosaccharides and stimulates the proliferation of human HaCaT keratinocytes. J. Biol. Chem. 277 (2000) 12456-12462
9. Fukumura D., Xavier R., Sugiura T., Chen Y., Park E.C., Lu N., Selig M., Nielsen G., Taksir T., Jain R.K., et al. Tumor induction of VEGF promoter activity in stromal cells. Cell 94 (1998) 715-725
10. Fusenig N.E., and Boukamp P. Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol. Carcinog 23 (1998) 144-158
11. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest. Dermatol 127 (2007) 526-537
12. Hinz B., and Gabbiani G. Cell-matrix and cell-cell contacts of myofibroblasts: role in connective tissue remodeling. Thromb. Haemost 90 (2003) 993-1002
13. Hinz B., Phan S.H., Thannickal V.J., Galli A., Bochaton-Piallat M.L., and Gabbiani G. The myofibroblast: one function, multiple origins. Am. J. Pathol 170 (2007) 1807-1816
14. Kalluri R., and Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer 6 (2006) 392-401
15. Kankuri E., Cholujova D., Comajova M., Vaheri A., and Bizik J. Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness. Cancer Res. 65 (2005) 9914-9922
16. Kunz-Schughart L.A., Heyder P., Schroeder J., and Knuechel R. A heterologous 3-D coculture model of breast tumor cells and fibroblasts to study tumor-associated fibroblast differentiation. Exp. Cell Res. 266 (2001) 74-86
17. Laeeq S., and Faust R. Modeling the cholesteatoma microenvironment: Coculture of HaCaT keratinocytes with WS1 fibroblasts induces MMP-2 activation, invasive phenotype, and proteolysis of the extracellular matrix. Laryngoscope 117 (2007) 313-318
18. Lederle W., Stark H.J., Skobe M., Fusenig N.E., and Mueller M.M. Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells. Am. J. Pathol 169 (2006) 1767-1783
19. Mueller M.M., and Fusenig N.E. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. Differentiation 70 (2002) 486-497
20. Mueller M.M., and Fusenig N.E. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4 (2004) 839-849
21. Orimo A., and Weinberg R.A. Stromal fibroblasts in cancer. A novel tumor-promoting cell type. Cell Cycle 5 (2006) 1597-1601
22. Pai R., Nakamura T., Moon W.S., and Tarnawski A.S. Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors. FASEB J 17 (2003) 1640-1647
23. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45
24. Pfaffl M.W., Horgan G.W., and Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30 (2002) e36
25. Rosen E.M., and Goldberg I.D. Regulation of angiogenesis by scatter factor. EXS 79 (1997) 193-208
26. Sappino A.P., Skalli O., Jackson B., Schurch W., and Gabbiani G. Smooth muscle differentiation in stromal cells of malignant and nonmalignant breast tissues. Int. J. Cancer 1 (1988) 707-712
27. Shephard P., Martin G., Smola-Hess S., Brunner G., Krieg T., and Smola H. Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. Am. J. Pathol 164 (2004) 2055-2066
28. Sirén V., Salmenperä P., Kankuri E., Bizik J., Sorsa T., Tervahartiala T., and Vaheri A. Cell-cell contact activation of fibroblasts increases the expression of matrix metalloproteinases. Ann. Med 38 (2006) 212-220
29. Skalli O., Schurch W., Seemaver T., Lagacé R., Montandon D., Pittet B., and Gabbiani G. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab. Invest 60 (1989) 275-285
30. Tomakidi P., Stark H.J., Herold-Mende C., Bosch F.X., Steinbauer H., Fusenig N.E., and Breitkreutz D. Discriminating expression of differentiation markers evolves in transplants of benign and malignant human skin keratinocytes through stromal interactions. J. Pathol 200 (2003) 298-307
31. Vaheri, A., in press. Nemosis. In: Schwab, M. (Ed.-in-chief), Encyclopedia of Cancer, second ed. Springer.
32. Vosseler S., Mirancea N., Bohlen P., Mueller M.M., and Fusenig N.E. Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants. Cancer Res. 65 (2005) 1294-1305
33. Yang X.H., Man X.Y., Cai S.Q., Yao Y.G., Bu Z.Y., and Zheng M. Expression of VEGFR-2 on HaCaT cells is regulated by VEGF and plays an active role in mediating VEGF induced effects. Biochem. Biophys. Res. Commun 349 (2006) 31-38
34. You L., and Kruse F.E. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway. Invest. Ophthalmol. Vis. Sci. 43 (2002) 72-81
35. Zha S., Yegnasubramanian V., Nelson W.G., Isaacs W.B., and De Marzo A.M. Cyclooxygenases in cancer: progress and perspective. Cancer Lett. 215 (2004) 1-20